Companies
/
Somatus
Healthtech
Somatus is a McLean, Virginia-based value-based kidney care company that partners with health plans and physicians to provide coordinated care for patients with chronic kidney disease and kidney failure.
$4.11B
+$1,398.86
4,007.92%
30 days ago
$34.90
Create an account to view live offerings, pricing, and market activity.
Sign in to view offerings and live market activity.
Sign up with Augment to see the latest market activity.
Somatus was founded in 2015 by Ikenna Okezie, based on the recognition that chronic kidney disease, a condition affecting a very significant number of Americans that can progress to kidney failure requiring dialysis or transplant if not properly managed, has historically received relatively fragmented, reactive care within the traditional U.S. healthcare system, with many patients not receiving adequate early intervention and care coordination until their condition had already progressed to a more advanced, costly, and difficult-to-manage stage, despite substantial evidence that earlier, more proactive kidney disease management can meaningfully slow disease progression and improve patient outcomes while reducing the very high costs associated with kidney failure and dialysis care. Somatus's model involves partnering with health insurance plans and nephrologists (kidney specialist physicians) to provide more comprehensive, proactive, and coordinated care for patients with chronic kidney disease, including care coordination support, patient education, and interventions aimed at slowing disease progression and helping patients better prepare for and manage the transition to dialysis or transplant if their kidney disease does progress to failure, rather than the more reactive, less coordinated care many chronic kidney disease patients have traditionally received. The company operates under value-based care arrangements with health plans, meaning Somatus takes on some financial accountability for the total cost and quality of care for the kidney disease patient populations it manages, aligning its financial incentives with actually improving patient outcomes and avoiding costly complications and unnecessary hospitalizations, rather than being paid simply based on the volume of services delivered regardless of patient outcomes, a payment model increasingly common across various chronic disease management companies given growing healthcare industry interest in value-based care arrangements as an alternative to traditional fee-for-service payment. Somatus's customers are primarily health insurance plans and nephrology physician practices that partner with the company to improve chronic kidney disease management for their covered patient populations. The company has raised substantial venture funding from investors including General Catalyst, Blue Cross Blue Shield Venture Partners, and Sonder Capital, reaching unicorn status, positioning itself as a prominent value-based kidney care company alongside competitors including Cricket Health and Strive Health.
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
